Rapidly progressive glomerulonephritis: current and evolving treatment strategies

Little, M.A.; Pusey, C.D.

Journal of Nephrology 17(Suppl): S10-S19

2004


ISSN/ISBN: 1121-8428
PMID: 15599880
Document Number: 568959
Rapidly progressive glomerulonephiritis (RPGN) must be diagnosed and treated quickly to prevent irreversible organ injury. The commonest cause of RPGN is anti-neutrophil cytoplasm antibody (ANCA) associated small vessel vasculitis, and the most severe is anti-glomerular basement membrane (GBM) antibody disease. In this review we address pathogenesis, diagnosis, treatment and outcome in these two entities, with emphasis on novel therapies.

Document emailed within 1 workday
Secure & encrypted payments